Dermal Phototoxicity Study
NCT04070742 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2019-09-11
Summary
Dermal Safety study to determine the Phototoxicity Potential of FMX-101 4% in Healthy Volunteers
Conditions
- Healthy
Interventions
- DRUG
-
FMX101
Sponsors & Collaborators
-
Vyne Therapeutics Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-17
- Primary Completion
- 2016-09-07
- Completion
- 2016-10-01
- FDA Drug
- Yes
More Related Trials
-
A Phase 1 Study of CDX-0159
NCT04146129 ·Status: COMPLETED ·Phase: PHASE1
-
Human Phototoxicity Test
NCT02751541 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers
NCT04321980 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic Impairment
NCT02170220 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
NCT03500627 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of CMX001 in Impaired Hepatic Function and Healthy Subjects
NCT05391724 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency
NCT04442347 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX
NCT01366378 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX
NCT01367483 ·Status: COMPLETED ·Phase: PHASE1
-
AV-101 Alone and in Combination With Probenecid in Healthy Subjects
NCT05280054 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial
NCT05277376 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers
NCT02393950 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Single Ascending Dose Safety Study of TNX-201 Capsules in Healthy Volunteers
NCT02290379 ·Status: COMPLETED ·Phase: PHASE1
-
Human Phototoxicity Test
NCT02750475 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects
NCT04416126 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Escalation Safety and Pharmacokinetic Study of ATX-101
NCT00618709 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability Study of FL-101 in Healthy Male and Female Subjects
NCT04983732 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
NCT01711762 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Seresis® in the Skin in Healthy Young Female Volunteers
NCT02191852 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function
NCT01563562 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Heat on Oxybutynin Release and Absorption From Oxybutynin Products
NCT03205605 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
NCT06539507 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults
NCT01050127 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment
NCT04634149 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat
NCT04299633 ·Status: COMPLETED ·Phase: PHASE1